High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer

International Journal of Cancer

Volumn 79, Issue 2, 1998, Pages 144-146

  Salven, Petri ^a   Ruotsalainen, Tarja ^a   Mattson, Karin ^a   Joensuu, Heikki ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; INTERFERON; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR CLASSIFICATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; ENDOTHELIAL GROWTH FACTORS; ETOPOSIDE; FEMALE; HUMANS; INTERFERON ALFA-2A; INTERFERON-ALPHA; LUNG NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031942430     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980417)79:2<144::AID-IJC8>3.0.CO;2-T     Document Type: Article

References (20)

1. BERSE, B., BROWN, L.K., VAN DE WATER, L., DVORAK, H.F. and SENGER, D.R., Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol. Biol. Cell. 3, 211-220 (1992).
2. DIRIX, L.Y., VERMEULEN, P.B., HUBENS, G., BENOY, I., MARTIN, M., DE POOTER, C. and VAN OOSTEROM, A.T., Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann. Oncol. 7, 843-848 (1996).
3. DVORAK, H.F., BROWN, L.F., DETMAR, M. and DVORAK, A.M., Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Amer. J. Pathol., 146, 1029-1039 (1995).
4. FERRARA, N., WINER, J., BURTON, T., ROWLAND, A., SIEGEL, M., PHILLIPS, H.S., TERRELL, T., KULLER, G.A. and LEVINSON, A.D., Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese-hamster ovary cells. J. clin. Invest., 91, 160-170 (1993).
5. FOLKMAN, J., Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med., 1, 27-31 (1995).
6. FREEMAN, M.R., SCHNECK, F.X., GAGNON, M.L., CORLESS, C., SOKER, S., NIKNEJAD, K., PEOPLES, G.E. and KLAGSBRUN, M., Peripheral-blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res., 55, 4140-4145 (1995).
7. GABRILOVICH, D.I., CHEN, H.L., GIRGIS, K.R., CUNNINGHAM, H.T., MENY, G.M., NADAF, S., KAVANAUGH, D. and CARBONE, D.P., Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dentritic cells. Nature Med., 2, 1096-1103 (1996).
8. HANAHAN, D. and FOLKMAN, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364 (1996).
9. HARRISON, P., WILBOURN, B., DEBILI, N., VAINCHENKER, W., BRETON GORIUS, J., LAWRIE, A.S., MASSE, J.M., SAVIDGE, G.F. and CRAMER, E.M., Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. J. clin. Invest., 84, 1320-1324 (1989).
10. KIM, K.J., LI, B., WINTER, J., ARMANINI, M., GILLETT, N., PHILLIPS, H.S. and FERRARA, N., Inhibition of vascular-endothelial-growth-factor-induccd an- giogenesis suppresses tumour growth in vivo. Nature (Lond)., 362, 841-844 (1993).
11. MATTSON, K., NIIRANEN, A., PYRHÖNEN, S., RISKA, H., MAASILTA, P., HALME, M., JEKUNEN, A., SARNA, S. and CANTELL, K., Concomitant chemotherapy (CT) and interferon alpha (IFNα) for SCLC (abstract). Proc. Amer. Soc. clin. Oncol., 14, 370 (1995).
12. MOHLE, R., GREEN, D., MOORE, M.A., NACHMAN, R.L. and RAFII, S., Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. nat. Acad. Sci. (Wash.), 94, 663-668 (1997).
13. RISAU, W., Mechanisms of angiogenesis. Nature (Lond.), 386, 671-674 (1997).
14. SALVEN, P., HEIKKILÄ, P., ANTTONEN, A., KAJANTI, M. and JOENSUU, H., Vascular endothelial growth factor in squamous-cell head-and-neck carcinoma: expression and prognostic significance. Modern Pathol. 10, 1128-1133 (1997a).
15. SALVEN, P., HEIKKILÄ, P. and JOENSUU, H., Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Brit. J. Cancer, 76, 930-934 (1997b).
16. SALVLN, P., MÄENPÄÄ, H., ORPANA, A., ALITALO, K. and JOENSUU, H., Serum VEGF is often elevated in disseminated cancer. Clin. Cancer Res., 6, 647-652 (1997c).
17. SALVEN, P., TEERENHOVI, L. and JOENSUU, H., A high pre-treatment serum vascular-endothelial-growth-factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood, 90, 3167-3172 (1997d).
18. TAKANO, S., YOSHII, Y., KONDO, S., SUZUKI, H., MARUNO, T., SHIRAI, S. and NOSE, T., Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain-tumor patients. Cancer Res., 56, 2185-2190 (1996).
19. YAMAMOTO, Y. and 12 OTHERS, Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res., 2, 821-826 (1996).
20. ZHANG, H.T., CRAFT, P., SCOTT, P.A., ZICHE, M., WHICH, H.A., HARRIS, A.L. and BICKNELL, R., Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast-carcinoma cells. J. nat. Cancer Inst., 87, 213-219 (1995).